Thus, given the fact that loss of a small region in chromosome 19q is associated with increased risk of recurrent disease, the aim of this study was to investigate the impact of the proteins HRNPM and SLC1A5, both of which are found in this region, on clinical factors, pathogenesis and prognosis in ovarian cancer. This evidence concerns the gene SLC1A5 and ovarian carcinoma.